May 2011 Briefing - Otolaryngology
Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for May 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Effect Estimates May Be Inflated in Biomarker Studies
TUESDAY, May 31 (HealthDay News) -- Biomarker effects are often overestimated in highly cited studies compared to the effects reported in subsequent meta-analyses of the same associations, according to a review published in the June 1 issue of the Journal of the American Medical Association.
Contact With Drug Industry Linked to Positive Attitudes
WEDNESDAY, May 25 (HealthDay News) -- The extent of contact that medical students have with the pharmaceutical industry is associated with positive attitudes about marketing, according to a review published online May 24 in PLoS Medicine.
Intratympanic Steroids Effectively Treat Hearing Loss
TUESDAY, May 24 (HealthDay News) -- Intratympanic corticosteroids are as effective as oral steroids for the treatment of sudden sensorineural hearing loss, according to a study published in the May 25 issue of the Journal of the American Medical Association.
Inappropriate Antibiotic Prescribing Common in Asthma
MONDAY, May 23 (HealthDay News) -- Inappropriate antibiotic prescribing appears to be relatively common among children with asthma, according to two studies published online May 23 in Pediatrics.
FDA: SimplyThick Should Not Be Used in Premature Infants
MONDAY, May 23 (HealthDay News) -- The U.S. Food and Drug Administration has notified parents, caregivers, and health care providers not to administer SimplyThick to infants born prior to 37 weeks, as the product may cause necrotizing enterocolitis (NEC), a life-threatening gastrointestinal condition.
CDC: Swimmer's Ear Results in Over Two Million Visits Yearly
FRIDAY, May 20 (HealthDay News) -- Acute otitis externa (AOE), also known as swimmer's ear, is associated with a large number of doctor visits and substantial medical costs annually, according a report in the May 20 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Many Medical Students Lack Confidence in Medical Law
FRIDAY, May 20 (HealthDay News) -- The majority of medical students lack confidence in their knowledge and skills across many areas of medical law, according to a study published online May 16 in the Journal of Medical Ethics.
Propranolol Effectively Treats Infantile Hemangiomas
WEDNESDAY, May 18 (HealthDay News) -- Propranolol appears to be an effective first-line therapy in the treatment of infantile head and neck hemangiomas, according to research published in the May issue of the Archives of Otolaryngology -- Head & Neck Surgery.
Triamcinolone Ineffective in Eustachian Tube Dysfunction
WEDNESDAY, May 18 (HealthDay News) -- Tympanometric manifestation of eustachian tube dysfunction (ETD) may not be normalized by treatment with intranasal aqueous triamcinolone acetonide (TAA-AQ), according to a study published in the May issue of the Archives of Otolaryngology -- Head & Neck Surgery.
Childhood Eczema, Rhinitis Predict Adult Asthma
FRIDAY, May 13 (HealthDay News) -- Children who have eczema and rhinitis may be more susceptible to atopic asthma in adulthood, according to research published online April 4 in the Journal of Allergy and Clinical Immunology.
Heller's Myotomy Not Superior Treatment for Achalasia
THURSDAY, May 12 (HealthDay News) -- Laparoscopic Heller's myotomy (LHM) appears no more effective than pneumatic dilation for treatment of achalasia, according to research published in the May 12 issue of the New England Journal of Medicine.
Medical Education Participants Recognize Funding Bias
WEDNESDAY, May 11 (HealthDay News) -- Although most medical professionals believe that commercial funding of continuing medical education (CME) introduces bias, most are not willing to pay higher fees to offset or eliminate such funding sources, according to a study published in the May 9 issue of the Archives of Internal Medicine.
Adding Omalizumab May Improve Uncontrolled Asthma
FRIDAY, May 6 (HealthDay News) -- Omalizumab appears to provide additional clinical benefits in patients with severe allergic asthma that is inadequately controlled with inhaled corticosteroids (ICS) and long-acting beta2-agonists (LABAs), according to a study published in the May 3 issue of the Annals of Internal Medicine.
Obstructive Sleep Apnea Better After Adenotonsillectomy
THURSDAY, May 5 (HealthDay News) -- In children with obstructive sleep apnea syndrome (OSAS), sleep-disordered breathing improves after adenotonsillectomy possibly due to decreases in the sympathetic activity of the autonomic nervous system, according to a study published in the May issue of Chest.
Leukotriene-Receptor Antagonists Effective in Asthma
WEDNESDAY, May 4 (HealthDay News) -- Use of a leukotriene-receptor antagonist (LTRA) may be as effective as an inhaled glucocorticoid as first-line controller therapy, and as effective as a long-acting beta2-agonist (LABA) as an add-on therapy, for the treatment of asthma patients, according to the findings of two pragmatic trials published in the May 5 issue of the New England Journal of Medicine.
CDC: Asthma Prevalence on the Rise in United States
TUESDAY, May 3 (HealthDay News) -- The prevalence of asthma among both adults and children has increased in the last decade, and asthma costs have increased in recent years as well, according to a report in the May 3 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.